NCT07249814

Brief Summary

This study aimed to compare the effectiveness and safety of fractionated versus bolus administration of different doses of hyperbaric bupivacaine (0.06 and 0.07 mg/cm height) combined with opioids in spinal anesthesia for cesarean section, with detailed evaluation of maternal hemodynamic effects, block characteristics and side effects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
99

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 30, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 14, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

November 25, 2025

Completed
Last Updated

November 25, 2025

Status Verified

November 1, 2025

Enrollment Period

12 months

First QC Date

November 14, 2025

Last Update Submit

November 18, 2025

Conditions

Keywords

Spinal AnesthesiaHypotensionHemodynamic StabilityBupivacaineBolus DoseFractionated DoseCesarean Section

Outcome Measures

Primary Outcomes (1)

  • Hemodynamic Stability (systolic, diastolic and mean arterial pressure, heart rate)

    Hemodynamic parameters were recorded every 2 minutes for 10 minutes, then every 5 minutes until 30 minutes, then every 15 minutes until surgery completion.

    Perioperative/Periprocedural - before spinal anesthesia and then during the cesarean section until its completion

Secondary Outcomes (1)

  • Spinal block characteristics (sensory block level and duration, motor block duration, analgesia duration)

    Perioperative/Periprocedural

Study Arms (3)

Bolus bupivacaine (0.07 mg/cm)

ACTIVE COMPARATOR
Procedure: Bolus anesthesia

Fractionated bupivacaine (0.07 mg/cm)

EXPERIMENTAL
Procedure: Fractionated anesthesia

Fractionated bupivacaine (0.06 mg/cm)

ACTIVE COMPARATOR
Procedure: Fractionated anesthesia

Interventions

* Group F7: received a fractionated administration of bupivacaine (0.07 mg/cm); * Group F6: received a fractionated administration of the reduced dose of bupivacaine (0.06 mg/cm).

Fractionated bupivacaine (0.06 mg/cm)Fractionated bupivacaine (0.07 mg/cm)

• Group B: received a bolus administration of the total dose of 0.5% hyperbaric bupivacaine (0.07 mg/cm height)

Bolus bupivacaine (0.07 mg/cm)

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • singleton full-term pregnancy scheduled for cesarean section under spinal anesthesia
  • ASA physical status II-III
  • age 18-50 years
  • height from 140 to 180 cm
  • body weight from 40 to 130 kg

You may not qualify if:

  • patient refusal
  • contraindications to spinal anesthesia
  • allergy to amide-type local anesthetics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kyiv Perinatal Center

Kyiv, Ukraine

Location

MeSH Terms

Conditions

Hypotension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.

Study Record Dates

First Submitted

November 14, 2025

First Posted

November 25, 2025

Study Start

June 30, 2024

Primary Completion

June 15, 2025

Study Completion

June 15, 2025

Last Updated

November 25, 2025

Record last verified: 2025-11

Locations